CATALAYER NEWS

As US-China pharma rivalry heats up, can Hong Kong’s US$8b fund be the global bridge?

Source: SCMP Business · 2026-08-07

Full article text is available in the Catalayer news terminal.

RELATED ON CATALAYER
Related Topics
China Trade & Tech Policy NewsBiotech & FDA News
RELATED MARKETS
Prediction Markets
Xi Jinping out before 2027?5%Will Gavin Newsom win the 2028 Democratic presidential nomination?14%Will Alexandria Ocasio-Cortez win the 2028 Democratic presidential nomination?21%
Open Catalayer terminal for live tracking →